Related Experiment Video
Updated: Jun 13, 2026

07:47
Longitudinal In Vivo Imaging of the Cerebrovasculature: Relevance to CNS Diseases
Published on: December 6, 2016
Slow-wave-modulated high-frequency oscillations reveal early network abnormalities in pre-pathological 5XFAD mice.
Pablo García-Peña1, Milagros Ramos2, Juan M López3
1Center for Biomedical Technology (CTB), Universidad Politécnica de Madrid, Madrid, Spain.
Neurobiology of Disease
|June 11, 2026
Summary
Early Alzheimer's disease (AD) shows altered brain activity before plaques form. Increased high-frequency oscillations and phase-amplitude coupling in mice may serve as early biomarkers for AD detection.
Area of Science:
- Neuroscience
- Electrophysiology
- Biomarkers
Background:
- Alzheimer's disease (AD) involves progressive neural network disruption and abnormal brain oscillations.
- Sensitive electrophysiological markers for early AD stages are limited.
- The 5XFAD mouse model exhibits amyloid-beta accumulation preceding plaque formation.
Purpose of the Study:
- Investigate intracranial EEG (iEEG) biomarkers for early network dysfunction in the 5XFAD mouse model of AD.
- Focus on electrophysiological changes in the pre-plaque stage of AD pathology.
- Identify sensitive markers for early-stage Alzheimer's disease.
Main Methods:
- Recorded iEEG from 5XFAD and wild-type mice at young, adult, and old ages.
- Analyzed spectral power, epileptiform activity, and phase-amplitude coupling (PAC).
- Correlated electrophysiological findings with histopathological markers of AD.
Main Results:
- Young 5XFAD mice, despite lacking plaques, showed reduced low-frequency power and increased high-frequency oscillation (HFO) power.
- Adult 5XFAD mice exhibited similar spectral changes, plus epileptiform activity and seizures.
- Pathological HFO activity was linked to altered PAC with slow oscillations, emerging before plaque deposition.
Conclusions:
- Increased HFO activity and dysregulated PAC are early electrophysiological signatures of cortical hyperexcitability in AD.
- These markers precede amyloid plaque formation and neurodegeneration.
- Combined HFO power and PAC metrics show translational potential as early AD biomarkers.
